Kalaris Therapeutics, Inc. Common Stock
KLRS • NASDAQ
Kalaris Therapeutics, Inc. Common Stock is a publicly traded company trading on NASDAQ, led by CEO Andrew Oxtoby, with a market cap of $123.6M.
CEOAndrew Oxtoby
Market Cap$123.6M
Next Earnings
Upcoming earnings announcement for Kalaris Therapeutics, Inc. Common Stock
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.53
Earnings History
Past 4 earnings reports for Kalaris Therapeutics, Inc. Common Stock
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.44Est: -$0.55 | +20.0% | - | — | — |
| Nov 12, 2025 | Q3 2025 | -$0.64Est: -$0.63 | -1.6% | - | — | — |
| Aug 13, 2025 | Q2 2025 | -$0.61Est: -$0.51 | -19.6% | - | — | — |
| May 14, 2025 | Q1 2025 | -$2.52 | — | - | — | — |